Indication

Latent bejel

Latent bejel refers to the asymptomatic, clinically quiescent phase of endemic syphilis, a chronic nonvenereal treponematosis caused by the spirochete *Treponema pallidum* subspecies *endemicum*. Read more about Latent bejel

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Latent bejel therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Latent bejel preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Latent bejel.

Latent bejel refers to the asymptomatic, clinically quiescent phase of endemic syphilis, a chronic nonvenereal treponematosis caused by the spirochete *Treponema pallidum* subspecies *endemicum*.

It primarily occurs in populations living in arid, rural regions of the Middle East and the Sahel, where primary and secondary mucocutaneous infections are typically acquired in childhood through skin-to-skin contact or shared utensils.

In this latent stage, active lesions involving the oral mucosa, skin, or bones have resolved, leaving patients entirely free of overt symptoms while remaining seropositive on nontreponemal and treponemal assays.

Pathophysiologically, the bacteria persist subclinically in deep tissues, carrying a long-term risk of reactivation into late, destructive tertiary disease marked by disfiguring gummatous lesions and periostitis of the bone and cartilage.

Personalize your experience

Follow Latent bejel and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it